Antifungal activity of the primycin complex and its main components A1, A2 and C1 on a Candida albicans clinical isolate, and their effects on the dynamic plasma membrane changes

Journal of Antibiotics

Volumn 66, Issue 2, 2013, Pages 67-72

  Virág, Eszter ^a   Belagyi, Joseph ^a   Kocsubé, Sándor ^b   Vágvölgyi, Csaba ^b   Pesti, Miklós ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

5 SASL; antifungal; Candida albicans; EPR; membrane fluidity; primycin; ST EPR

Indexed keywords

MACROLIDE; PRIMYCIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; ELECTRON SPIN RESONANCE; FUNGAL STRAIN; GROWTH INHIBITION; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHASE SEPARATION; PRIORITY JOURNAL; TRANSITION TEMPERATURE;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CELL MEMBRANE; MACROLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 84874595657     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2012.103     Document Type: Article

References (26)

1. Tortorano, A.M. et al. Candidaemia in Europe: epidemiology and resistance. Int. J. Antimicrob. Agents 27, 359-366 (2006).
2. Berman, J. & Sudbery, P. E. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat. Rev. Gen. 3, 918-930 (2002). (Pubitemid 35423504)
3. Klepser, M. E. Candida resistance and its clinical relevance. Pharmacotherapy 26, 68-75 (2006).
4. Nogradi, M. Primycin (Ebrimycin)-A new topical antibiotic. Drugs Today 24, 563-566 (1988).
5. Uri, J. V. & Actor, P. Crystallization and antifungal activity of primycin. J. Antibiot. 32, 1207-1209 (1979). (Pubitemid 10076389)
6. Uri, J. V. Antibacterial activity of primycin against multiple strains of Gram-positive bacteria. Acta Microbiol. Hung. 33, 141-146 (1986).
7. Blasko, K. & Gyorgyi, S. Alkali ion transport of primycin modified erythrocytes. Acta Biol. Med. Germ. 40, 465-469 (1981). (Pubitemid 12214094)
8. Balint, G. Favorable observations with Ebrimycin gel in the outpatient department of surgery. Ther. Hung. 35, 140-142 (1987). (Pubitemid 17132379)
9. Meszaros, C. & Vezekenyi, K. Use of Ebrimycin gel in dermatology. Ther. Hung. 35, 77-79 (1987). (Pubitemid 17143869)
10. Papp, T., Menesi, L. & Szalai, I. Experiences in the Ebrimycin gel treatment of burns. Ther. Hung. 38, 125-128 (1990). (Pubitemid 20385326)
11. Nyilasi, I. et al. In vitro interactions between primycin and different statins in their effects against some clinically important fungi. J. Med. Microbiol. 59, 200-205 (2010).
12. Virag, E., Belagyi, J., Gazdag, Z., Vagvolgyi, C. & Pesti, M. Direct in vivo interaction of the antibiotic primycin with the plasma membrane of Candida albicans: an EPR study. Biochim. Biophys. Acta (1818)42-48, 2012.
13. Virag, E., Pesti, M. & Kunsagi-Mate, S. Competitive hydrogen bonds associated with the effect of primycin antibiotic on oleic acid as a building block of plasma membranes. J. Antibiot. 63, 113-117 (2010).
14. Virag, E., Pesti, M. & Kunsagi-Mate, S. Complex formation between primycin and ergosterol. Entropy-driven initiation of modification of the fungal plasma membrane structure. J. Antibiot. 65, 193-196 (2012).
15. Virag, E. et al. In vivo interaction of the antibiotic primycin on a Candida albicans clinical isolate and its ergosterol-less mutant. Acta Biol. Hung. 63, 42-55 (2012).
16. Szilagyi, I., Dekany, G., Frank, J., Horvath, G. & Kulcsar, G. Oxipricin, a new antibiotic. United States Patent num 4,873,348 (1989).
17. Prasad, R. Candida albicans. Cellular and molecular biology (Springer-Verlag, Heidelberg, 1991).
18. NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. National Committee for Clinical Laboratory Standards. Document M27-ANCCLS, Wayne, PA (1997).
19. Horvath, L. I. & Marsh, D. Analysis of multicomponent saturation transfer ESR spectra using the integral method: application to membrane systems. J. Magn. Reson. 54, 363-373 (1983).
20. Goldman, S. A., Bruno, G. V. & Freed, J. H. Estimating slow motional rotational correlation times for nitroxides by electron spin resonance. J. Phys. Chem. 76, 1858-1860 (1972).
21. Knowles, P. F., Marsh, D. & Rattle, H. W. E. Magnetic resonance of biomolecules (Wiley Interscience, 1976).
22. Pesti, M., Gazdag, Z. & Belagyi, J. In vivo interaction of trivalent chromium with yeast plasma membrane, as revealed by EPR spectroscopy. FEMS Microbiol. Lett. 182, 375-380 (2000). (Pubitemid 30006934)
23. Eamann, M. & Deleu, M. From biological membranes to biomimetic model membranes. Biotechnol. Agron. Soc. Environ. 14, 719-736 (2010).
24. Squire, T. C. & Thomas, D. D. Methodology for increased precision in saturation transfer electron paramagnetic resonance studies of rotational dynamics. Biophys. J 49, 921-929 (1986).
25. Hemminga, M. A., Van der Dries, I. J., Magusin, P. C. M. M., Van Dusschoten, D. & Van der Berg, C. In Water management in the design and distribution of quality foods (eds, Roos, Y. H., Leslie, R. B. & Lillford, P. J.) (Technomic Publishing, Lancaster, 1999).
26. Wisniewska, A., Draus, J. & Subczynsky, W. K. Is a fluid mosaic model of biological membranes fully relevant? Studies on lipid organization in model and biological membranes. Lett. Cell. Molec. Biol. 8, 147-159 (2003). (Pubitemid 36534577)